Phio Pharmaceuticals Corp. (PHIO) has been given the go-ahead by the Safety Monitoring Committee to proceed with dose escalation in its phase Ib clinical trial of PH-762.PH-762, the company's lead drug candidate works by silencing the PD-1 gene implicated in various forms of skin cancer.The phase Ib clinical trial is a multi-center, dose-escalating trial designed to evaluate the safety and tolerab...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.